Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.

Oxid Med Cell Longev · 2022 · PMC9423987 · PMID 36046686

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

[ 21 ] showed that the expression level of PDIA3 protein showed an increasing trend from normal mucosa to early stage of oral squamous cell carcinoma, and it could be used as a potential biomarker to assist the diagnosis of oral squamous cell carcinoma.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.